PURA Finalizes On Increased Investment In ALKM To Produce New CBD Infused Products

Rhea-AI Summary

Puration, Inc. (OTC Pink: PURA) has completed a capital investment in Alkame Holdings, Inc. (OTC Pink: ALKM), increasing its stake to fund the development of new CBD infused products. PURA had initially acquired a 5% interest in ALKM and will now support the formulation and production setup at ALKM's facility. This investment is considered to yield returns through product sales without incurring long-term debt for ALKM. Puration collaborates with North American Cannabis Holdings, Inc. (OTC Pink: USMJ) for marketing these new products.

Positive

• PURA increased its investment in ALKM, indicating confidence in product development.
• The investment aims to create new CBD infused products, potentially broadening PURA's product line.
• No long-term debt or equity impact for ALKM from this investment.

Negative

• The investment is at risk, as with all investments, leading to potential financial uncertainty.

Dallas, Texas, June 14, 2021 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today finalized with Alkame Holdings, Inc. (OTC Pink: ALKM) on the previously announced commitment for PURA to increase its investment in ALKM.

In an earlier capital investment initiative, PURA acquired a five percent interest in ALKM. 

PURA is working with ALKM and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) in the development of a series of new CBD infused products. PURA’s new investment will be directed at funding ALKM to formulate the products and set up the ALKM plant for producing the products. USMJ will manage marketing of the new CBD infused products.

The investment transaction is now complete. PURA has advanced funds for ALKM to formulate products and set up the ALKM plant for producing new products.  While the investment, like all investments, is at risk, PURA expects the investment to ultimately result in ALKM creating new products for PURA whereby PURA’s return will come from the sale of the new products with no long-term debt or equity impact to ALKM. 

For more information on Puration, visit http://www.purationinc.com
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Puration, Inc. will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FAQ

What recent investment did PURA make in ALKM?

PURA finalized an increased investment in Alkame Holdings, aiming to fund the development of new CBD infused products.

What percentage of ALKM did PURA initially acquire?

PURA initially acquired a 5% interest in Alkame Holdings.

How will PURA's investment support product development?

PURA's investment will fund the formulation of products and setup of ALKM's production plant.

What role does USMJ play in this investment?

North American Cannabis Holdings, Inc. (USMJ) will manage the marketing of the new CBD infused products.

Is PURA's investment in ALKM without risks?

No, the investment is at risk, as typical with all investments.